Recent Edits
Log In
Articles
Sign Up
Cases
Courses
Quiz
Donate
About
ADVERTISEMENT: Radiopaedia is free thanks to our supporters and advertisers. Become a Gold Supporter and see no third-party ads.
Articles
Cases
Courses
REGISTER NOW

Autosomal dominant polycystic kidney disease

Changed by Joachim Feger, 10 Jan 2024
Back to revision history
Disclosures - updated 27 Nov 2023: Nothing to disclose

Updates to Article Attributes

Body was changed:

Autosomal dominant polycystic kidney disease (ADPKD), also sometimes referred to as "adult polycystic kidney disease", is an inherited form of adult cystic renal disease. 

Epidemiology

Autosomal dominant polycystic kidney disease is one of the most common serious hereditary diseases, found in 1:400 to 1:1000 individuals, and is by far the most common inherited cause of end stage-stage renal failure (ESRF) 6. It accounts for 4-10% of all cases of ESRF 6. 

Associations

A number ofSeveral conditions are well recognised as being associated with ADPKD 1,3,5,6:

Diagnosis

Genetic testing is costly, so diagnosis is commonly made by a combination of family history and cyst detection. Advances in technology mean that smaller cysts can be identified and this has led to suggestions to modify the criteria, e.g. two or more cysts in each kidney in US in an at-risk individual aged 30-40 years17. High-resolution T2 FSE is highly sensitive for subcentimetre cysts and more objective. Ten or more cysts in the 16-49 year age group were found to have sensitivity and positive predictive value of 100% in at-risk individuals; a limit of five cysts can be used to identify suitable related renal donors 17.

Clinical presentation

The kidneys are normal at birth, and with time develop multiple cysts. At the age of 30 years, approximately 68% of patients will have visible cysts by ultrasound 3. Cyst number and size increasesincrease with age and all patients eventually demonstrate cystic change. By the age of 60 years, approximately 50% of patients have end stage-stage renal failure. The risk of renal cancer is not increased.

Clinical presentation is variable and includes 1: 

  • dull flank pain of variable severity and time course: most common

  • abdominal or flank masses

  • haematuria

  • hypertension: usually develops at the same time as renal failure

  • renal functional impairment to renal failure

Pathology

Macroscopically the kidneys demonstrate a large number of cysts of variable size (from a few mm to many cm), in both the cortex and medulla. They are filled with fluid of variable colour (from clear or straw coloured-coloured to altered blood or chocolate-coloured to purulent when infected).

Genetics

The majority of cases are inherited in an autosomal dominant fashion. In around 28% of cases, no family history is apparent16 and the disease may be due to a spontaneous mutation 1.

Three genes have been identified, with slightly different phenotypes 1,3,13:

  • PKD1

    • located on chromosome 16p

    • 80% of cases

    • encodes polycystin-1 transmembrane protein

    • presentation is earlier and more likely to progress to end stage-stage renal failure, average age of 54 years16

  • PKD2

    • chromosome 4q

    • 15% of cases

    • encodes polycystin-2 14  

    • less severe, ESRD at an average age 74 years16

  • GANAB (rare)

    • ​chromosome 11q13

    • liver cysts common +/- hepatic dysfunction

    • mild renal disease, ESRF unusual

The main abnormality is in the cilia-centromere complex of tubular epithelial cells 14. The defect results in cystic dilatation of the renal tubules (of all parts of the nephron) in a minority of nephrons. The cysts are variable in size and result, resulting in compression and atrophy of the remainder of the kidney, increased renin and erythropoietin secretion, and gradual renal dysfunction. 

Radiographic features

Genetic testing is costly, so diagnosis is commonly made by a combination of family history and cyst detection. Advances in technology mean that smaller cysts can be identified and this has led to suggestions to modify the criteria, e.g. two or more cysts in each kidney on US in an at risk individual aged 30-40 years17. High-resolution T2 FSE is highly sensitive for subcentimetre cysts and more objective. Ten or more cysts in 16-49 year age group was found to have sensitivity and positive predictive value of 100% in at-risk individuals; a limit of five cysts can be used to identify suitable related renal donors17.

Full imaging assessment of patients with autosomal dominant polycystic kidney disease can be challenging, simply due to the size and number of the cysts and associated mass effect on adjacent structures. All cysts need to be assessed for atypical features, that may reflect complications (e.g. haemorrhagebleeding or infection) or malignancy (i.e. renal cell carcinoma) 2. 

Enlargement of the kidneys is associated with poorer renal function. Therefore, renal volume measurement can be used to predict the risk of chronic renal failure 15.

Plain radiograph

Plain films have no role in the surveillance of patients with established ADPKD. The diagnosis may be suspected when the renal outlines are enlarged, multilobulated or difficult to discern, with associated displacement of loops of bowel. 

Multiple calcifications may be seen which may have multiple ring configurations. 

On intravenous urography, "Swiss cheese nephrogram" is seen due to multiple radiolucencies noted as a result ofdue to multiple renal cysts. "Spiderleg pyelogram" is also described since stretched out and attenuated pelvicalyceal system is seen as a result of the mass effect caused by renal cysts.

Ultrasound

Ultrasound is fast, relatively inexpensive and lacks ionising radiation. It can suggest the diagnosis and assess for cyst complications. 

Simple renal cysts will appear anechoic with well-defined thin walls, posterior acoustic enhancement (amplification) and lateral shadowing (extinction) 3. 

Cysts with haemorrhage or infection will demonstrate echogenic material within the cyst, without internal blood flow. Calcification may develop in cyst walls. Renal cell carcinomas in contrast, although usually cystic in the setting of ADPKD, will have solid components with blood flow. CEUS is useful to demonstrate enhancement.

Perinephric and intrarenal haematomas may occur in the context of minor trauma.

Cysts may be detected in the liver, spleen, pancreas and seminal vesicles.

CT

Simple cysts appear as rounded structures with near water-water attenuation and thin, regular walls. Complications such as haemorrhage or infection raise the attenuation of the cyst contents and induce dystrophic wall calcification.

A complex cystic mass with an enhancing solid component may indicate renal cell carcinoma (RCC).  The Bosniak classification of renal cysts is of limited value in ADPKD. Subtraction CT or, MRI or DECT are sensitive to enhancement.

MRI

High-resolution T2-weighted MRI is the most sensitive modality for the detection of small renal cysts.Simple cysts are thin-walled and the contents appear similar to water.

  • T1: low signal

  • T2: high signal 

  • T1 C+ (Gd)

    • consider using ACR group II ultra-low risk-risk contrast media to avoid nephrogenic systemic fibrosis

    • simple cysts should not have any solid enhancing-enhancing components

    • presence of enhancement of a solid component or septa should raise the possibility of a renal cell carcinoma (RCC) (N.B. infected cysts may peripherally enhance, as do islands of trapped renal tissue). Subtraction MR may be helpful.

Treatment and prognosis

ESRF requiring transplant or dialysis eventually develops in many patients (45% by the age of 60). Patients with PKD1 mutations are more likely to progress to ESRF and often do so at an earlier age 1. Patients with a larger height-adjusted total kidney volume are at greater risk of ESRF and may benefit from vasopressin receptor antagonists which slow cyst expansion16. EGFR is often stable until the disease is advanced, therefore size and morphology are more useful predictors of outcome. The Mayo Clinic Imaging Classification uses size and morphology to predict disease course. Radiomics and textural analysis show promise in predicting decline.

Complications

Complications may be both local (i.e. of the kidney) or of other organ systems. 

Renal complications include 1,3:

Unlike in some other congenital cystic kidney diseases, there is no increased risk for renal cell carcinoma (RCC) unless the patient is undergoing prolonged dialysis 11. 

Distant complications include:

Differential diagnosis

General imaging differential considerations include:

Practical points

  • Diagnosisdiagnosis is usually made by imaging at risk-risk individuals

  • the height-adjusted total kidney volume for both kidneys and the quantity of remaining normal renal tissue are the best indicators of future renal function and the need for vasopressin receptor antagonists.

See also

  • -<p><strong>Autosomal dominant polycystic kidney disease (ADPKD)</strong>, also sometimes referred to as "adult polycystic kidney disease", is an inherited form of <a href="/articles/adult-cystic-renal-disease">adult cystic renal disease</a>.&nbsp;</p><h4>Epidemiology</h4><p>Autosomal dominant polycystic kidney disease is one of the most common serious hereditary diseases,&nbsp;found in 1:400 to 1:1000 individuals, and is by far the most common inherited cause of <a href="/articles/end-stage-renal-disease-2">end stage renal failure (ESRF)</a> <sup>6</sup>. It accounts for 4-10% of all cases of ESRF <sup>6</sup>.&nbsp;</p><h5>Associations</h5><p>A number of conditions are well recognised as being associated with ADPKD <sup>1,3,5,6</sup>:</p><ul>
  • +<p><strong>Autosomal dominant polycystic kidney disease (ADPKD)</strong>, also sometimes referred to as "adult polycystic kidney disease", is an inherited form of <a href="/articles/adult-cystic-renal-disease">adult cystic renal disease</a>.&nbsp;</p><h4>Epidemiology</h4><p>Autosomal dominant polycystic kidney disease is one of the most common serious hereditary diseases,&nbsp;found in 1:400 to 1:1000 individuals, and is by far the most common inherited cause of <a href="/articles/end-stage-renal-disease-2">end-stage renal failure (ESRF)</a> <sup>6</sup>. It accounts for 4-10% of all cases of ESRF <sup>6</sup>.&nbsp;</p><h5>Associations</h5><p>Several conditions are well recognised as being associated with ADPKD <sup>1,3,5,6</sup>:</p><ul>
  • -<li><p><a href="/articles/hypertension">hypertension</a>: up to 80% adults <sup>6</sup></p></li>
  • +<li><p><a href="/articles/hypertension">hypertension</a>: up to 80% of adults <sup>6</sup></p></li>
  • -</ul><h4>Clinical presentation</h4><p>The kidneys are normal at birth, and with time develop multiple cysts. At the age of 30 years, approximately 68% of patients will have visible cysts by ultrasound <sup>3</sup>. Cyst number and size increases with age and all patients eventually demonstrate cystic change. By the age of 60 years, approximately 50% of patients have <a href="/articles/end-stage-renal-disease-2">end stage renal failure</a>. The risk of renal cancer is not increased.</p><p>Clinical presentation is variable and includes <sup>1</sup>:&nbsp;</p><ul>
  • +</ul><h4>Diagnosis</h4><p>Genetic testing is costly, so diagnosis is commonly made by a combination of family history and cyst detection. Advances in technology mean that smaller cysts can be identified and this has led to suggestions to modify the criteria, e.g. two or more cysts in each kidney in US in an at-risk individual aged 30-40 years<sup>17</sup>. High-resolution T2 FSE is highly sensitive for subcentimetre cysts and more objective. Ten or more cysts in the 16-49 year age group were found to have sensitivity and positive predictive value of 100% in at-risk individuals; a limit of five cysts can be used to identify suitable related renal donors <sup>17</sup>.</p><h4>Clinical presentation</h4><p>The kidneys are normal at birth, and with time develop multiple cysts. At the age of 30 years, approximately 68% of patients will have visible cysts by ultrasound <sup>3</sup>. Cyst number and size increase with age and all patients eventually demonstrate cystic change. By the age of 60 years, approximately 50% of patients have <a href="/articles/end-stage-renal-disease-2">end-stage renal failure</a>. The risk of renal cancer is not increased.</p><p>Clinical presentation is variable and includes <sup>1</sup>:&nbsp;</p><ul>
  • -</ul><h4>Pathology</h4><p>Macroscopically the kidneys demonstrate a large number of cysts of variable size (from a few mm to many cm), in both the cortex and medulla. They are filled with fluid of variable colour (from clear or straw coloured to altered blood or chocolate-coloured to purulent when infected).</p><h5>Genetics</h5><p>The majority of cases are inherited in an autosomal dominant fashion. In around 28% of cases, no family history is apparent<sup>16</sup> and the disease may be due to a spontaneous mutation <sup>1</sup>.</p><p>Three genes have been identified, with slightly different phenotypes <sup>1,3,13</sup>:</p><ul>
  • +</ul><h4>Pathology</h4><p>Macroscopically the kidneys demonstrate a large number of cysts of variable size (from a few mm to many cm), in both the cortex and medulla. They are filled with fluid of variable colour (from clear or straw-coloured to altered blood or chocolate-coloured to purulent when infected).</p><h5>Genetics</h5><p>The majority of cases are inherited in an autosomal dominant fashion. In around 28% of cases, no family history is apparent<sup>16</sup> and the disease may be due to a spontaneous mutation <sup>1</sup>.</p><p>Three genes have been identified, with slightly different phenotypes <sup>1,3,13</sup>:</p><ul>
  • -<li><p>presentation is earlier and more likely to progress to end stage renal failure, average age 54 years<sup>16</sup></p></li>
  • +<li><p>presentation is earlier and more likely to progress to end-stage renal failure, average age of 54 years<sup>16</sup></p></li>
  • -<li><p>less severe, ESRD at average age 74 years<sup>16</sup></p></li>
  • +<li><p>less severe, ESRD at an average age 74 years<sup>16</sup></p></li>
  • -</ul><p>The main abnormality is in the cilia-centromere complex of tubular epithelial cells <sup>14</sup> . The defect results in cystic dilatation of the renal tubules (of all parts of the nephron) in a minority of nephrons. The cysts are variable in size and result in compression and atrophy of the remainder of the kidney, increased renin and erythropoietin secretion, and gradual renal dysfunction.&nbsp;</p><h4>Radiographic features</h4><p>Genetic testing is costly, so diagnosis is commonly made by a combination of family history and cyst detection. Advances in technology mean that smaller cysts can be identified and this has led to suggestions to modify the criteria, e.g. two or more cysts in each kidney on US in an at risk individual aged 30-40 years<sup>17</sup>. High-resolution T2 FSE is highly sensitive for subcentimetre cysts and more objective. Ten or more cysts in 16-49 year age group was found to have sensitivity and positive predictive value of 100% in at-risk individuals; a limit of five cysts can be used to identify suitable related renal donors<sup>17.</sup></p><p>Full imaging assessment of patients with autosomal dominant polycystic kidney disease can be challenging, simply due to the size and number of the cysts and associated mass effect on adjacent structures. All cysts need to be assessed for atypical features, that may reflect complications (e.g. haemorrhage or infection) or malignancy (i.e. <a href="/articles/renal-cell-carcinoma-1">renal cell carcinoma</a>) <sup>2</sup>.&nbsp;</p><p>Enlargement of the kidneys is associated with poorer renal function. Therefore, renal volume measurement can be used to predict the risk of chronic renal failure <sup>15</sup>.</p><h5>Plain radiograph</h5><p>Plain films have no role in the surveillance of patients with established ADPKD. The diagnosis may be suspected when the renal outlines are enlarged, multilobulated or difficult to discern, with associated displacement of loops of bowel.&nbsp;</p><p>Multiple calcifications may be seen which may have multiple ring configurations.&nbsp;</p><p>On intravenous urography, "<a href="/articles/swiss-cheese-nephrogram">Swiss cheese nephrogram</a><strong><em>"</em></strong>&nbsp;is seen due to multiple radiolucencies noted as a result of multiple renal cysts. <strong><em>"</em></strong><a href="/articles/spider-leg-pyelogram">Spiderleg pyelogram</a><strong><em>"</em></strong> is also described since stretched out and attenuated pelvicalyceal system is seen as a result of mass effect caused by renal cysts.</p><h5>Ultrasound</h5><p>Ultrasound is fast, relatively inexpensive and lacks ionising radiation. It can suggest the diagnosis and assess for cyst complications.&nbsp;</p><p>Simple renal cysts will appear anechoic with well-defined thin walls, posterior acoustic enhancement (amplification) and lateral shadowing (extinction) <sup>3</sup>.&nbsp;</p><p>Cysts with haemorrhage or infection will demonstrate echogenic material within the cyst, without internal blood flow. Calcification may develop in cyst walls. Renal cell carcinomas in contrast, although usually cystic in the setting of ADPKD, will have solid components with blood flow.&nbsp;CEUS is useful to demonstrate enhancement.</p><p>Perinephric and intrarenal haematomas may occur in the context of minor trauma.</p><p>Cysts may be detected in the liver, spleen, pancreas and seminal vesicles.</p><h5>CT</h5><p>Simple cysts appear as rounded structures with near water attenuation and thin, regular walls. Complications such as haemorrhage or infection raise the attenuation of the cyst contents and induce dystrophic wall calcification.</p><p>A complex cystic mass with an enhancing solid component may indicate <a href="/articles/renal-cell-carcinoma-1">renal cell carcinoma (RCC)</a>.&nbsp; The Bosniak classification of renal cysts is of limited value in ADPKD. Subtraction CT or MRI or DECT are sensitive to enhancement.</p><h5>MRI</h5><p>High-resolution T2-weighted MRI is the most sensitive modality for detection of small renal cysts. Simple cysts are thin-walled and the contents appear similar to water.</p><ul>
  • +</ul><p>The main abnormality is in the cilia-centromere complex of tubular epithelial cells <sup>14</sup>. The defect results in cystic dilatation of the renal tubules (of all parts of the nephron) in a minority of nephrons. The cysts are variable in size, resulting in compression and atrophy of the remainder of the kidney, increased renin and erythropoietin secretion, and gradual renal dysfunction.&nbsp;</p><h4>Radiographic features</h4><p>Full imaging assessment of patients with autosomal dominant polycystic kidney disease can be challenging, simply due to the size and number of the cysts and associated mass effect on adjacent structures. All cysts need to be assessed for atypical features, that may reflect complications (e.g. bleeding or infection) or malignancy (i.e. <a href="/articles/renal-cell-carcinoma-1">renal cell carcinoma</a>) <sup>2</sup>.&nbsp;</p><p>Enlargement of the kidneys is associated with poorer renal function. Therefore, renal volume measurement can be used to predict the risk of chronic renal failure <sup>15</sup>.</p><h5>Plain radiograph</h5><p>Plain films have no role in the surveillance of patients with established ADPKD. The diagnosis may be suspected when the renal outlines are enlarged, multilobulated or difficult to discern, with associated displacement of loops of bowel.&nbsp;</p><p>Multiple calcifications may be seen which may have multiple ring configurations.&nbsp;</p><p>On intravenous urography, "<a href="/articles/swiss-cheese-nephrogram">Swiss cheese nephrogram</a><strong><em>"</em></strong>&nbsp;is seen due to multiple radiolucencies noted due to multiple renal cysts. <strong><em>"</em></strong><a href="/articles/spider-leg-pyelogram">Spiderleg pyelogram</a><strong><em>"</em></strong> is also described since stretched out and attenuated pelvicalyceal system is seen as a result of the mass effect caused by renal cysts.</p><h5>Ultrasound</h5><p>Ultrasound is fast, relatively inexpensive and lacks ionising radiation. It can suggest the diagnosis and assess for cyst complications.&nbsp;</p><p>Simple renal cysts will appear anechoic with well-defined thin walls, posterior acoustic enhancement (amplification) and lateral shadowing (extinction) <sup>3</sup>.&nbsp;</p><p>Cysts with haemorrhage or infection will demonstrate echogenic material within the cyst, without internal blood flow. Calcification may develop in cyst walls. Renal cell carcinomas in contrast, although usually cystic in the setting of ADPKD, will have solid components with blood flow.&nbsp;CEUS is useful to demonstrate enhancement.</p><p>Perinephric and intrarenal haematomas may occur in the context of minor trauma.</p><p>Cysts may be detected in the liver, spleen, pancreas and seminal vesicles.</p><h5>CT</h5><p>Simple cysts appear as rounded structures with near-water attenuation and thin, regular walls. Complications such as haemorrhage or infection raise the attenuation of the cyst contents and induce dystrophic wall calcification.</p><p>A complex cystic mass with an enhancing solid component may indicate <a href="/articles/renal-cell-carcinoma-1">renal cell carcinoma (RCC)</a>.&nbsp; The Bosniak classification of renal cysts is of limited value in ADPKD. Subtraction CT, MRI or DECT are sensitive to enhancement.</p><h5>MRI</h5><p>High-resolution T2-weighted MRI is the most sensitive modality for the detection of small renal cysts. Simple cysts are thin-walled and the contents appear similar to water.</p><ul>
  • -<li><p>consider using ACR group II ultra-low risk contrast media to avoid <a href="/articles/nephrogenic-systemic-fibrosis">nephrogenic systemic fibrosis</a></p></li>
  • -<li><p>simple cysts should not have any solid enhancing components</p></li>
  • +<li><p>consider using ACR group II ultra-low-risk contrast media to avoid <a href="/articles/nephrogenic-systemic-fibrosis">nephrogenic systemic fibrosis</a></p></li>
  • +<li><p>simple cysts should not have any solid-enhancing components</p></li>
  • -</ul><h4>Treatment and prognosis</h4><p>ESRF requiring transplant or dialysis eventually develops in many patients (45% by the age of 60). Patients with <em>PKD1</em> mutations are more likely to progress to ESRF and often do so at an earlier age <sup>1</sup>.&nbsp;Patients with a larger height-adjusted total kidney volume are at greater risk of ESRF and may benefit from vasopressin receptor antagonists which slow cyst expansion<sup>16</sup>. EGFR is often stable until disease is advanced, therefore size and morphology are more useful predictors of outcome. The Mayo Clinic Imaging Classification uses size and morphology to predict disease course. Radiomics and textural analysis show promise in predicting decline.</p><h5>Complications</h5><p>Complications may be both local (i.e. of the kidney) or of other organ systems.&nbsp;</p><p>Renal complications include <sup>1,3</sup>:</p><ul>
  • -<li><p>progression to end stage renal failure&nbsp;</p></li>
  • +</ul><h4>Treatment and prognosis</h4><p>ESRF requiring transplant or dialysis eventually develops in many patients (45% by the age of 60). Patients with <em>PKD1</em> mutations are more likely to progress to ESRF and often do so at an earlier age <sup>1</sup>.&nbsp;Patients with a larger height-adjusted total kidney volume are at greater risk of ESRF and may benefit from vasopressin receptor antagonists which slow cyst expansion<sup>16</sup>. EGFR is often stable until the disease is advanced, therefore size and morphology are more useful predictors of outcome. The Mayo Clinic Imaging Classification uses size and morphology to predict disease course. Radiomics and textural analysis show promise in predicting decline.</p><h5>Complications</h5><p>Complications may be both local (i.e. of the kidney) or of other organ systems.&nbsp;</p><p>Renal complications include <sup>1,3</sup>:</p><ul>
  • +<li><p>progression to end-stage renal failure&nbsp;</p></li>
  • -<li><p>cyst haemorrhage or infection-resulting in acute pain</p></li>
  • +<li><p>cyst haemorrhage or infection resulting in acute pain</p></li>
  • -<p>primary renal disease related cysts</p>
  • +<p>primary renal disease-related cysts</p>
  • -<p>Diagnosis usually made by imaging at risk individuals</p>
  • +<p>diagnosis is usually made by imaging at-risk individuals</p>

References changed:

  • 1. S. Morcos, Henrik Thomsen. Urogenital Imaging. (2009) ISBN: 9780470510896 - <a href="http://books.google.com/books?vid=ISBN9780470510896">Google Books</a>
  • 2. Ali Guermazi. Imaging of Kidney Cancer. (2005) ISBN: 9783540211297 - <a href="http://books.google.com/books?vid=ISBN9783540211297">Google Books</a>
  • 3. Nahm A, Henriquez D, Ritz E. Renal Cystic Disease (ADPKD and ARPKD). Nephrol Dial Transplant. 2002;17(2):311-4. <a href="https://doi.org/10.1093/ndt/17.2.311">doi:10.1093/ndt/17.2.311</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/11812890">Pubmed</a>
  • 4. Ong A. Screening for Intracranial Aneurysms in ADPKD. BMJ. 2009;339(sep21 2):b3763. <a href="https://doi.org/10.1136/bmj.b3763">doi:10.1136/bmj.b3763</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19770180">Pubmed</a>
  • 5. Peña J, Pernaute R, Vicente de Vera C. Is ADPKD Associated with Small-Bowel Diverticular Disease? Nephrol Dial Transplant. 2000;15(11):1890-1. <a href="https://doi.org/10.1093/ndt/15.11.1890">doi:10.1093/ndt/15.11.1890</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/11071990">Pubmed</a>
  • 6. Robert W. Schrier. Diseases of the Kidney and Urinary Tract. (2007) ISBN: 9780781793070 - <a href="http://books.google.com/books?vid=ISBN9780781793070">Google Books</a>
  • 7. Ronald J. Zagoria. Genitourinary Radiology. (2004) ISBN: 9780323018425 - <a href="http://books.google.com/books?vid=ISBN9780323018425">Google Books</a>
  • 8. Joseph K. T. Lee. Computed Body Tomography with MRI Correlation. (2006) ISBN: 9780781745260 - <a href="http://books.google.com/books?vid=ISBN9780781745260">Google Books</a>
  • 9. Karhunen P. Adult Polycystic Liver Disease and Biliary Microhamartomas (Von Meyenburg's Complexes). Acta Pathol Microbiol Immunol Scand A. 1986;94(6):397-400. <a href="https://doi.org/10.1111/j.1699-0463.1986.tb03011.x">doi:10.1111/j.1699-0463.1986.tb03011.x</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/3811921">Pubmed</a>
  • 10. Rahbari-Oskoui F, Mittal A, Mittal P, Chapman A. Renal Relevant Radiology: Radiologic Imaging in Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2014;9(2):406-15. <a href="https://doi.org/10.2215/CJN.08940813">doi:10.2215/CJN.08940813</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/24370765">Pubmed</a>
  • 11. Donna E. Hansel, Christopher J. Kane, Gladell P. Paner et al. The Kidney. (2015) ISBN: 9781493932863 - <a href="http://books.google.com/books?vid=ISBN9781493932863">Google Books</a>
  • 12. Katabathina V, Kota G, Dasyam A, Shanbhogue A, Prasad S. Adult Renal Cystic Disease: A Genetic, Biological, and Developmental Primer. Radiographics. 2010;30(6):1509-23. <a href="https://doi.org/10.1148/rg.306105513">doi:10.1148/rg.306105513</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21071372">Pubmed</a>
  • 13. Porath B, Gainullin V, Cornec-Le Gall E et al. Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Am J Hum Genet. 2016;98(6):1193-207. <a href="https://doi.org/10.1016/j.ajhg.2016.05.004">doi:10.1016/j.ajhg.2016.05.004</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/27259053">Pubmed</a>
  • 14. Vinay Kumar, Abul K. Abbas, Jon C. Aster. Robbins & Cotran Pathologic Basis of Disease. (2020) ISBN: 9780323531139 - <a href="http://books.google.com/books?vid=ISBN9780323531139">Google Books</a>
  • 17. Pei Y, Hwang Y, Conklin J et al. Imaging-Based Diagnosis of Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2015;26(3):746-53. <a href="https://doi.org/10.1681/ASN.2014030297">doi:10.1681/ASN.2014030297</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25074509">Pubmed</a>
  • 1. Morcos SK, Morcos S, Thomsen H. Urogenital Imaging, A Problem-Oriented Approach. Wiley. (2009) ISBN:0470510897. <a href="http://books.google.com/books?vid=ISBN0470510897">Read it at Google Books</a> - <a href="http://www.amazon.com/gp/product/0470510897?ie=UTF8&tag=radiopaediaor-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=0470510897">Find it at Amazon</a><div class="ref_v2"></div>
  • 2. Guermazi A. Imaging of kidney cancer. Springer Verlag. (2006) ISBN:3540211292. <a href="http://books.google.com/books?vid=ISBN3540211292">Read it at Google Books</a> - <a href="http://www.amazon.com/gp/product/3540211292?ie=UTF8&tag=radiopaediaor-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=3540211292">Find it at Amazon</a><div class="ref_v2"></div>
  • 3. Nahm AM, Henriquez DE, Ritz E. Renal cystic disease (ADPKD and ARPKD). Nephrol. Dial. Transplant. 2002;17 (2): 311-4. <a href="http://dx.doi.org/10.1093/ndt/17.2.311">doi:10.1093/ndt/17.2.311</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/11812890">Pubmed citation</a><div class="ref_v2"></div>
  • 4. Ong AC. Screening for intracranial aneurysms in ADPKD. BMJ. 2009;339 (sep21 2): b3763. <a href="http://dx.doi.org/10.1136/bmj.b3763">doi:10.1136/bmj.b3763</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/19770180">Pubmed citation</a><div class="ref_v2"></div>
  • 5. Peña JM, Pernaute R, Vicente de vera C. Is ADPKD associated with small-bowel diverticular disease? Nephrol. Dial. Transplant. 2000;15 (11): 1890-1. <a href="http://dx.doi.org/10.1093/ndt/15.11.1890">doi:10.1093/ndt/15.11.1890</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/11071990">Pubmed citation</a><div class="ref_v2"></div>
  • 6. Schrier RW. Diseases of the kidney &amp; urinary tract. Lippincott Williams & Wilkins. (2007) ISBN:0781793076. <a href="http://books.google.com/books?vid=ISBN0781793076">Read it at Google Books</a> - <a href="http://www.amazon.com/gp/product/0781793076?ie=UTF8&tag=radiopaediaor-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=0781793076">Find it at Amazon</a><div class="ref_v2"></div>
  • 7. Zagoria RJ. Genitourinary radiology, the requisites. Mosby Inc. (2004) ISBN:0323018424. <a href="http://books.google.com/books?vid=ISBN0323018424">Read it at Google Books</a> - <a href="http://www.amazon.com/gp/product/0323018424?ie=UTF8&tag=radiopaediaor-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=0323018424">Find it at Amazon</a><div class="ref_v2"></div>
  • 8. Lee JK. Computed body tomography with MRI correlation. Lippincott Williams & Wilkins. (2006) ISBN:0781745268. <a href="http://books.google.com/books?vid=ISBN0781745268">Read it at Google Books</a> - <a href="http://www.amazon.com/gp/product/0781745268?ie=UTF8&tag=radiopaediaor-20&linkCode=as2&camp=1789&creative=9325&creativeASIN=0781745268">Find it at Amazon</a><div class="ref_v2"></div>
  • 9. Karhunen PJ. Adult polycystic liver disease and biliary microhamartomas (von Meyenburg's complexes). (1986) Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology. 94 (6): 397-400. <a href="https://www.ncbi.nlm.nih.gov/pubmed/3811921">Pubmed</a> <span class="ref_v4"></span>
  • 10. Rahbari-Oskoui F, Mittal A, Mittal P et-al. Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2014;9 (2): 406-15. <a href="http://dx.doi.org/10.2215/CJN.08940813">doi:10.2215/CJN.08940813</a> - <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913246">Free text at pubmed</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/24370765">Pubmed citation</a><span class="auto"></span>
  • 11. Donna E. Hansel, Christopher J. Kane, Gladell P. Paner, Sam S. Chang. The Kidney. <a href="https://books.google.co.uk/books?vid=ISBN9781493932863">ISBN: 9781493932863</a><span class="ref_v4"></span>
  • 12. Katabathina VS, Kota G, Dasyam AK, Shanbhogue AK, Prasad SR. Adult renal cystic disease: a genetic, biological, and developmental primer. (2010) Radiographics : a review publication of the Radiological Society of North America, Inc. 30 (6): 1509-23. <a href="https://doi.org/10.1148/rg.306105513">doi:10.1148/rg.306105513</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/21071372">Pubmed</a> <span class="ref_v4"></span>
  • 13. Porath B, Gainullin V, Cornec-Le Gall E et al. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Am J Hum Genet. 2016;98(6):1193-1207. <a href="https://doi.org/10.1016/j.ajhg.2016.05.004">doi:10.1016/j.ajhg.2016.05.004</a>
  • 14. Robbins & Cotran Pathologic Basis Of Disease, Tenth edition, ISBN: 978-0-323-53113-9
  • 17. Pei Y, Hwang Y, Conklin J et al. Imaging-Based Diagnosis of Autosomal Dominant Polycystic Kidney Disease. JASN. 2014;26(3):746-53. <a href="https://doi.org/10.1681/asn.2014030297">doi:10.1681/asn.2014030297</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25074509">Pubmed</a>

ADVERTISEMENT: Supporters see fewer/no ads

Articles

By Section:

By System:

Cases

Radiopaedia.org

Contact Us
Terms of Use
Privacy Policy
Licensing
Sponsorship
Developers

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.

© 2005–2024 Radiopaedia.org